Am J Psychiatry 160:13-23, January 2003
© 2003 American Psychiatric Association
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
Shitij Kapur, M.D., Ph.D., F.R.C.P.C.
OBJECTIVE: The clinical hallmark of schizophrenia is psychosis. The objective of this overview is to link the neurobiology (brain), the phenomenological experience (mind), and pharmacological aspects of psychosis-in-schizophrenia into a unitary framework. METHOD: Current ideas regarding the neurobiology and phenomenology of psychosis and schizophrenia, the role of dopamine, and the mechanism of action of antipsychotic medication were integrated to develop this framework. RESULTS: A central role of dopamine is to mediate the "salience" of environmental events and internal representations. It is proposed that a dysregulated, hyperdopaminergic state, at a "brain" level of description and analysis, leads to an aberrant assignment of salience to the elements of one’s experience, at a "mind" level. Delusions are a cognitive effort by the patient to make sense of these aberrantly salient experiences, whereas hallucinations reflect a direct experience of the aberrant salience of internal representations. Antipsychotics "dampen the salience" of these abnormal experiences and by doing so permit the resolution of symptoms. The antipsychotics do not erase the symptoms but provide the platform for a process of psychological resolution. However, if antipsychotic treatment is stopped, the dysregulated neurochemistry returns, the dormant ideas and experiences become reinvested with aberrant salience, and a relapse occurs. CONCLUSIONS: The article provides a heuristic framework for linking the psychological and biological in psychosis. Predictions of this hypothesis, particularly regarding the possibility of synergy between psychological and pharmacological therapies, are presented. The author describes how the hypothesis is complementary to other ideas about psychosis and also discusses its limitations.
This article has been cited by other articles:
|
|
|
|
 
D. M. Barch
Emotion, Motivation, and Reward Processing in Schizophrenia Spectrum Disorders: What We Know and Where We Need to Go
Schizophr Bull,
July 17, 2008;
(2008)
sbn092v1.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. K. Murray, F. Cheng, L. Clark, J. H. Barnett, A. D. Blackwell, P. C. Fletcher, T. W. Robbins, E. T. Bullmore, and P. B. Jones
Reinforcement and Reversal Learning in First-Episode Psychosis
Schizophr Bull,
July 15, 2008;
(2008)
sbn078v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Langdon, P. B. Ward, and M. Coltheart
Reasoning Anomalies Associated With Delusions in Schizophrenia
Schizophr Bull,
July 11, 2008;
(2008)
sbn069v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Faure, S. M. Reynolds, J. M. Richard, and K. C. Berridge
Mesolimbic Dopamine in Desire and Dread: Enabling Motivation to Be Generated by Localized Glutamate Disruptions in Nucleus Accumbens
J. Neurosci.,
July 9, 2008;
28(28):
7184 - 7192.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Harrow and T. H. Jobe
How Frequent is Chronic Multiyear Delusional Activity and Recovery in Schizophrenia: A 20-Year Multi-follow-up
Schizophr Bull,
July 9, 2008;
(2008)
sbn074v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Kumar, G. Waiter, T. Ahearn, M. Milders, I. Reid, and J. D. Steele
Abnormal temporal difference reward-learning signals in major depression
Brain,
June 25, 2008;
(2008)
awn136v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. D. Honey, P. R. Corlett, A. R. Absalom, M. Lee, E. Pomarol-Clotet, G. K. Murray, P. J. McKenna, E. T. Bullmore, D. K. Menon, and P. C. Fletcher
Individual Differences in Psychotic Effects of Ketamine Are Predicted by Brain Function Measured under Placebo
J. Neurosci.,
June 18, 2008;
28(25):
6295 - 6303.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Schmidt, D. S. Chapin, J. Cianfrogna, M. L. Corman, M. Hajos, J. F. Harms, W. E. Hoffman, L. A. Lebel, S. A. McCarthy, F. R. Nelson, et al.
Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia
J. Pharmacol. Exp. Ther.,
May 1, 2008;
325(2):
681 - 690.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Veiga-Martinez, M. Perez-Alvarez, and J. M. Garcia-Montes
Acceptance and Commitment Therapy Applied to Treatment of Auditory Hallucinations
Clinical Case Studies,
April 1, 2008;
7(2):
118 - 135.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. Horsley, P. Moran, and H. Cassaday
Appetitive overshadowing is disrupted by systemic amphetamine but not by electrolytic lesions to the nucleus accumbens shell
J Psychopharmacol,
March 1, 2008;
22(2):
172 - 181.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. Collip, I. Myin-Germeys, and J. Van Os
Does the Concept of "Sensitization" Provide a Plausible Mechanism for the Putative Link Between the Environment and Schizophrenia?
Schizophr Bull,
March 1, 2008;
34(2):
220 - 225.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Kumra, J. V. Oberstar, L. Sikich, R. L. Findling, J. M. McClellan, S. Vinogradov, and S. Charles Schulz
Efficacy and Tolerability of Second-Generation Antipsychotics in Children and Adolescents With Schizophrenia
Schizophr Bull,
January 1, 2008;
34(1):
60 - 71.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. D. HOWES, A. J. MONTGOMERY, M. ASSELIN, R. M. MURRAY, P. M. GRASBY, and P. K. McGUIRE
Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis
The British Journal of Psychiatry,
December 1, 2007;
191(51):
s13 - s18.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. R. BROOME, L. C. JOHNS, I. VALLI, J. B. WOOLLEY, P. TABRAHAM, C. BRETT, L. VALMAGGIA, E. PETERS, P. A. GARETY, and P. K. McGUIRE
Delusion formation and reasoning biases in those at clinical high risk for psychosis
The British Journal of Psychiatry,
December 1, 2007;
191(51):
s38 - s42.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. A. Gibbs, K. H. Naudts, E. P. Spencer, and A. S. David
The Role of Dopamine in Attentional and Memory Biases for Emotional Information
Am J Psychiatry,
October 1, 2007;
164(10):
1603 - 1609.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. YUII, M. SUZUKI, and M. KURACHI
Stress Sensitization in Schizophrenia
Ann. N.Y. Acad. Sci.,
October 1, 2007;
1113(1):
276 - 290.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Brignell, J. Rosenthal, and H. V. Curran
Pharmacological manipulations of arousal and memory for emotional material: effects of a single dose of methylphenidate or lorazepam
J Psychopharmacol,
September 1, 2007;
21(7):
673 - 683.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P.R. Corlett, G.K. Murray, G.D. Honey, M.R.F. Aitken, D.R. Shanks, T.W. Robbins, E.T. Bullmore, A. Dickinson, and P.C. Fletcher
Disrupted prediction-error signal in psychosis: evidence for an associative account of delusions
Brain,
September 1, 2007;
130(9):
2387 - 2400.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Stone, P. D. Morrison, and L. S. Pilowsky
Review: Glutamate and dopamine dysregulation in schizophrenia a synthesis and selective review
J Psychopharmacol,
June 1, 2007;
21(4):
440 - 452.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P.R. Corlett, G.D. Honey, and P.C. Fletcher
From prediction error to psychosis: ketamine as a pharmacological model of delusions
J Psychopharmacol,
May 1, 2007;
21(3):
238 - 252.
[Abstract]
[PDF]
|
|
|
|
|
|
|
B. L. Herbel and H. Stelmach
Involuntary Medication Treatment for Competency Restoration of 22 Defendants With Delusional Disorder
J Am Acad Psychiatry Law,
March 1, 2007;
35(1):
47 - 59.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Vallesi, T. Shallice, and V. Walsh
Role of the Prefrontal Cortex in the Foreperiod Effect: TMS Evidence for Dual Mechanisms in Temporal Preparation
Cereb Cortex,
February 1, 2007;
17(2):
466 - 474.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Morgan and H. Fisher
Environment and Schizophrenia: Environmental Factors in Schizophrenia: Childhood Trauma--A Critical Review
Schizophr Bull,
January 1, 2007;
33(1):
3 - 10.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Almeida and G. Ranjith
Using Pramipexole in Neuropsychiatry: A Cautionary Note
J Neuropsychiatry Clin Neurosci,
November 1, 2006;
18(4):
556 - 557.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Kuipers, P. Garety, D. Fowler, D. Freeman, G. Dunn, and P. Bebbington
Cognitive, Emotional, and Social Processes in Psychosis: Refining Cognitive Behavioral Therapy for Persistent Positive Symptoms
Schizophr Bull,
October 1, 2006;
32(suppl_1):
S24 - S31.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. van der Gaag
A Neuropsychiatric Model of Biological and Psychological Processes in the Remission of Delusions and Auditory Hallucinations
Schizophr Bull,
October 1, 2006;
32(suppl_1):
S113 - S122.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. I. Velligan, R. S. Kern, and J. M. Gold
Cognitive Rehabilitation for Schizophrenia and the Putative Role of Motivation and Expectancies
Schizophr Bull,
July 1, 2006;
32(3):
474 - 485.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. R. Corlett, G. D. Honey, M. R. F. Aitken, A. Dickinson, D. R. Shanks, A. R. Absalom, M. Lee, E. Pomarol-Clotet, G. K. Murray, P. J. McKenna, et al.
Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosis.
Arch Gen Psychiatry,
June 1, 2006;
63(6):
611 - 621.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. W Robbins
Synthesizing Schizophrenia: A Bottom-Up, Symptomatic Approach
Schizophr Bull,
October 1, 2005;
31(4):
854 - 864.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Lehrer, B. T. Christian, J. Mantil, A. C. Murray, B. R. Buchsbaum, T. R. Oakes, W. Byne, E. M. Kemether, and M. S. Buchsbaum
Thalamic and Prefrontal FDG Uptake in Never Medicated Patients With Schizophrenia
Am J Psychiatry,
May 1, 2005;
162(5):
931 - 938.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Kapur, T. Arenovich, O. Agid, R. Zipursky, S. Lindborg, and B. Jones
Evidence for Onset of Antipsychotic Effects Within the First 24 Hours of Treatment
Am J Psychiatry,
May 1, 2005;
162(5):
939 - 946.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. M. Semple, A. M. McIntosh, and S. M. Lawrie
Cannabis as a risk factor for psychosis: systematic review
J Psychopharmacol,
March 1, 2005;
19(2):
187 - 194.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. A. Morey, S. Inan, T. V. Mitchell, D. O. Perkins, J. A. Lieberman, and A. Belger
Imaging Frontostriatal Function in Ultra-High-Risk, Early, and Chronic Schizophrenia During Executive Processing
Arch Gen Psychiatry,
March 1, 2005;
62(3):
254 - 262.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Hunt, K. Kessal, and R. Garcia
Ketamine Induces Dopamine-Dependent Depression of Evoked Hippocampal Activity in the Nucleus Accumbens in Freely Moving Rats
J. Neurosci.,
January 12, 2005;
25(2):
524 - 531.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Sarter, C. L Nelson, and J. P Bruno
Cortical Cholinergic Transmission and Cortical Information Processing in Schizophrenia
Schizophr Bull,
January 1, 2005;
31(1):
117 - 138.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. L. CRANE
On Biology, Phenomenology, and Pharmacology in Schizophrenia
Am J Psychiatry,
February 1, 2004;
161(2):
376 - 376.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Rosenkranz, H. Moore, and A. A. Grace
The Prefrontal Cortex Regulates Lateral Amygdala Neuronal Plasticity and Responses to Previously Conditioned Stimuli
J. Neurosci.,
December 3, 2003;
23(35):
11054 - 11064.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Owen, A. Tulloch, R. Harland, and M. Broome
Scientific psychiatry?
The British Journal of Psychiatry,
December 1, 2003;
183(6):
564 - 564.
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2003
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
